Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
MEDI
41
HOLDINGS
14%
ALSO IN PPH
PPH
27
HOLDINGS
21%
ALSO IN MEDI
SECTOR DRIFT (MEDI minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDI |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 20.7% | 21.0% | 20.7% |
|
ABBVIE INC | 4.7% | 4.1% | 4.1% |
|
CENCORA INC | 2.1% | 3.1% | 2.1% |
|
MERCK & CO. INC. | 2.1% | 9.3% | 2.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 1.2% | 6.0% | 1.2% |
MEDI Overweight Relative to PPH
|
ASCENDIS PHARMA A/S | 15.0% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 5.2% |
|
VAXCYTE, INC. | 4.6% |
|
INTUITIVE SURGICAL INC | 4.5% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.8% |
|
INSMED INC | 3.6% |
|
ABIVAX SA-ADR | 3.5% |
|
DANAHER CORP | 2.4% |
|
NATERA INC | 2.4% |
|
REVOLUTION MEDICINES, INC. | 2.3% |
MEDI Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -10.8% |
|
MERCK & CO. INC. | -7.2% |
|
PFIZER INC | -4.8% |
|
NOVO-NORDISK A/S-SPONS ADR | -4.8% |
|
BRISTOL-MYERS SQUIBB CO | -4.5% |
 |
SANOFI-AVENTIS-ADR | -4.3% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.3% |
|
ASTRAZENECA PLC-SPONS ADR | -4.2% |
|
JOHNSON & JOHNSON | -4.2% |
|
MCKESSON CORP | -3.8% |